We're Hopeful That Qurient (KOSDAQ:115180) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Qurient (KOSDAQ:115180) has seen its share price rise 176% over the last year, delighting many shareholders. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?

In light of its strong share price run, we think now is a good time to investigate how risky Qurient's cash burn is. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'.

Advertisement

Does Qurient Have A Long Cash Runway?

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. In June 2025, Qurient had ₩44b in cash, and was debt-free. Looking at the last year, the company burnt through ₩27b. So it had a cash runway of approximately 20 months from June 2025. While that cash runway isn't too concerning, sensible holders would be peering into the distance, and considering what happens if the company runs out of cash. You can see how its cash balance has changed over time in the image below.

debt-equity-history-analysis
KOSDAQ:A115180 Debt to Equity History August 28th 2025

See our latest analysis for Qurient

How Well Is Qurient Growing?

Some investors might find it troubling that Qurient is actually increasing its cash burn, which is up 31% in the last year. To be fair, given that fact it's hardly inspiring to see that the operating revenue was flat year on year. Considering both these factors, we're not particularly excited by its growth profile. Of course, we've only taken a quick look at the stock's growth metrics, here. This graph of historic earnings and revenue shows how Qurient is building its business over time.

How Easily Can Qurient Raise Cash?

Even though it seems like Qurient is developing its business nicely, we still like to consider how easily it could raise more money to accelerate growth. Companies can raise capital through either debt or equity. Many companies end up issuing new shares to fund future growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

Qurient's cash burn of ₩27b is about 5.8% of its ₩460b market capitalisation. That's a low proportion, so we figure the company would be able to raise more cash to fund growth, with a little dilution, or even to simply borrow some money.

How Risky Is Qurient's Cash Burn Situation?

On this analysis of Qurient's cash burn, we think its cash burn relative to its market cap was reassuring, while its increasing cash burn has us a bit worried. While we're the kind of investors who are always a bit concerned about the risks involved with cash burning companies, the metrics we have discussed in this article leave us relatively comfortable about Qurient's situation. On another note, Qurient has 2 warning signs (and 1 which doesn't sit too well with us) we think you should know about.

Of course Qurient may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

Valuation is complex, but we're here to simplify it.

Discover if Qurient might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About KOSDAQ:A115180

Qurient

A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.

Excellent balance sheet with low risk.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2533.3% undervalued
158 users have followed this narrative
0 users have commented on this narrative
27 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0328.6% undervalued
35 users have followed this narrative
3 users have commented on this narrative
12 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.527.2% undervalued
19 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.723.9% undervalued
47 users have followed this narrative
3 users have commented on this narrative
20 users have liked this narrative

Updated Narratives

RO
RockeTeller
SSV logo
RockeTeller on Southern Silver Exploration ·

302 Million Oz Silver Project in Mexico: Low Cost Underground Giant Ready to Explode

Fair Value:CA$32.198.0% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
J_
J_Tyrader
OSCR logo
J_Tyrader on Oscar Health ·

7/8/26 — Oscar Health: Trading 95.4% below Fair Value with +2070.2% Upside Potential

Fair Value:US$583.3495.2% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
andre_santos
PG logo
andre_santos on Procter & Gamble ·

Procter & Gamble - A Fundamental Valuation

Fair Value:US$107.5235.6% overvalued
26 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28020.0% undervalued
277 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.1% overvalued
141 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0942.2% undervalued
165 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative